Home300966 • SHE
add
Hubei Goto Biopharm Co Ltd
Nakaraang pagsara
¥18.31
Sakop ng araw
¥18.26 - ¥19.20
Sakop ng taon
¥12.03 - ¥25.70
Market cap
2.10B CNY
Average na Volume
5.09M
P/E ratio
-
Dividend yield
0.09%
Primary exchange
SHE
Mga balita tungkol sa merkado
MarketWatch
1 araw ang nakalipas
Wall Street sees ‘no alternative’ to U.S. stocks in 2025. Here’s why.
0.072%
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 131.57M | 12.24% |
Gastos sa pagpapatakbo | 23.60M | 6.30% |
Net na kita | -9.04M | -270.23% |
Net profit margin | -6.87 | -251.66% |
Kita sa bawat share | — | — |
EBITDA | -9.80M | -173.91% |
Aktuwal na % ng binabayarang buwis | 35.67% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 130.49M | -5.98% |
Kabuuang asset | 2.70B | 21.75% |
Kabuuang sagutin | 1.67B | 37.63% |
Kabuuang equity | 1.03B | — |
Natitirang share | 115.28M | — |
Presyo para makapag-book | 2.25 | — |
Return on assets | -1.50% | — |
Return on capital | -1.97% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -9.04M | -270.23% |
Cash mula sa mga operasyon | 59.16M | 21.18% |
Cash mula sa pag-invest | -151.60M | -64.14% |
Cash mula sa financing | -75.30M | -1,169.55% |
Net change in cash | -167.64M | -360.99% |
Malayang cash flow | -169.79M | -800.76% |
Tungkol
Itinatag
May 15, 2006
Website
Mga Empleyado
631
